Jason Butch's Insider Trades & SAST Disclosures

Jason Butch's most recent trade in Agile Therapeutics Inc was a trade of 6,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 9, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Agile Therapeutics Inc
Jason Butch Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2022 6,000 6,000 - - Employee Stock Option (Right to Buy)
Agile Therapeutics Inc
Jason Butch Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2022 40,000 40,000 - - Employee Stock Option (Right to Buy)
Agile Therapeutics Inc
Jason Butch Principal Accounting Officer Purchase of securities on an exchange or from another person at price $ 2.01 per share. 26 Mar 2021 8,642 18,642 (0%) 0% 2.0 17,370 Common Stock
Agile Therapeutics Inc
Jason Butch Principal Accounting Officer Purchase of securities on an exchange or from another person at price $ 1.99 per share. 26 Mar 2021 1,358 20,000 (0%) 0% 2.0 2,702 Common Stock
Agile Therapeutics Inc
Jason Butch Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2021 25,000 25,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades